IP Library Granted Patent US 9,637,725
Granted Patent B2
US 9,637,725 · App. 14/366,127 · Granted May 2, 2017

Polypeptides having catalase activity and polynucleotides encoding same

Inventors: Ye Liu (Beijing, CN); Junxin Duan (Beijing, CN); Yu Zhang (Beijing, CN); Lan Tang (Beijing, CN)
Assignee: Novozymes Inc.
C12N9/0065C12P3/00C12P19/02D06L3/11C12Y111/01006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,637,725
App. No.
14/366,127
Granted
May 2, 2017
Kind
B2
Abstract

Provided are isolated polypeptides having catalase activity and polynucleotides encoding the polypeptides. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.

Claims (27)

1. A process for degrading or hydrolyzing a cellulosic material, comprising: contacting the cellulosic material with a cellulolytic enzyme composition and an isolated polypeptide to thereby degrade or hydrolyze the cellulosic material, wherein said isolated polypeptide has catalase activity and is selected from the group consisting of:

a) a polypeptide comprising an amino acid sequence having at least 95% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8, and

b) a fragment of the sequence of amino acids 20 to 741 of SEQ ID NO: 8, wherein the fragment has catalase activity.

2. The process of claim 1 , wherein said isolated polypeptide comprises an amino acid sequence having at least 97% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

3. The process of claim 1 , wherein said isolated polypeptide comprises an amino acid sequence having at least 98% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

4. The process of claim 1 , wherein said isolated polypeptide comprises an amino acid sequence having at least 99% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

5. The process of claim 1 , wherein said isolated polypeptide comprises the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

6. The process of claim 1 , wherein said isolated polypeptide is encoded by a polynucleotide that hybridizes under high stringency conditions with the full-length complement of the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7, wherein the high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide for 12 to 24 hours, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.

7. The process of claim 1 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 95% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

8. The process of claim 1 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 97% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

9. The process of claim 1 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 99% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

10. The process of claim 1 , wherein said isolated polypeptide is a variant of the sequence of amino acids 20 to 741 of SEQ ID NO: 8, wherein the variant is modified by a substitution, deletion, and/or insertion at one or more positions in the amino acid sequence of 20 to 741 of SEQ ID NO: 8, and wherein said isolated polypeptide comprises an amino acid sequence having at least 95% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8 and has catalase activity.

11. A process for producing a fermentation product, comprising:

(a) saccharifying a cellulosic material with a cellulolytic enzyme composition and an isolated polypeptide to produce a saccharified cellulosic material, wherein the isolated polypeptide has catalase activity and is selected from the group consisting of:

i) a polypeptide comprising an amino acid sequence having at least 95% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8, and

ii) a fragment of the sequence of amino acids 20 to 741 of SEQ ID NO: 8, wherein the fragment has catalase activity;

(b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and optionally

(c) recovering the fermentation product from the fermentation.

12. The process of claim 11 , wherein said isolated polypeptide comprises an amino acid sequence having at least 97% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

13. The process of claim 11 , wherein said isolated polypeptide comprises an amino acid sequence having at least 98% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

14. The process of claim 11 , wherein said isolated polypeptide comprises an amino acid sequence having at least 99% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

15. The process of claim 11 , wherein said isolated polypeptide comprises the sequence of amino acids 20 to 741 of SEQ ID NO: 8.

16. The process of claim 11 , wherein said isolated polypeptide is encoded by a polynucleotide that hybridizes under high stringency conditions with the full-length complement of the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7, wherein the high stringency conditions are defined as prehybridization and hybridization at 42° C. in 5×SSPE, 0.3% SDS, 200 micrograms/ml sheared and denatured salmon sperm DNA, and 50% formamide for 12 to 24 hours, followed by washing three times each for 15 minutes using 2×SSC, 0.2% SDS at 65° C.

17. The process of claim 11 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 95% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

18. The process of claim 11 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 97% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

19. The process of claim 11 , wherein said isolated polypeptide is encoded by a polynucleotide comprising a nucleic acid sequence having at least 99% sequence identity to the nucleic acid sequence of nucleotides 58 to 2476 of SEQ ID NO: 7.

20. The process of claim 11 , wherein said isolated polypeptide is a variant of the sequence of amino acids 20 to 741 of SEQ ID NO: 8, wherein the variant is modified by a substitution, deletion, and/or insertion at one or more positions in the amino act sequence of 20 to 741 of SEQ ID NO: 8, and wherein said isolated polypeptide comprises an amino acid sequence having at least 95% sequence identity to the sequence of amino acids 20 to 741 of SEQ ID NO: 8 and has catalase activity.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 21, 2019
From: NOVOZYMES, INC.
To: UNITED STATES DEPARTMENT OF ENERGY
Reel/Frame 050120/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2014
From: LIU, YE; DUAN, JUNXIN; ZHANG, YU; TANG, LAN
To: NOVOZYMES INC.
Reel/Frame 033119/0457 →
Priority Claims (1)
CN PCT/CN2011/084230 · Dec 19, 2011 · national
Continuity (2)
Provisional Application 61582913 · Jan 4, 2012
Related Publication 20140335572A1 · Nov 13, 2014